Squeeze
Squeeze, licence 80070166: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- SculptYou International Inc.
- NPN or DIN-HM
- 80070166
- Status
- Active licence
- Licence date
- 9 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
arrêté du 16 avril 2026 (JORFTEXT000053907152). French orders suspending food supplements containing a plant (Official Journal), checked against the text, retrieved 23 October 2026.
Order published in the French Official Journal, read on Légifrance.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 300 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Arctostaphylos uva-ursi Source : Feuille | 50.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2000 mg Potency : 7.0 % Caffeine | 100.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 30.0 % (+)-Catechin | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 50.0 % Polyphenols | Not specified | Not calculated |
| Garcinia gummi-gutta Source : Fruit Extract : Matériel brut sec Extraction ratio : 3.0:1.0 Dry plant equivalent : 450.0 mg Potency : 0.0 Hydroxycitric acid | 150.0 mg | Not calculated |
| Vaccinium macrocarpon Source : Fruit | 100.0 mg | Not calculated |
| Equisetum arvense Source : Sommité | 100.0 mg | Not calculated |
| Vitamine C Source : Vitamine C | 100.0 mg | 300,000 µg |
| Taraxacum officinale Source : Feuille Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 500.0 mg | 50.0 mg | Not calculated |
| Petroselinum crispum Source : Sommité | 50.0 mg | Not calculated |
| Juniperus communis Source : Fruit | 10.0 mg | Not calculated |
| Piper nigrum Source : Fruit Extract : Matériel brut sec Extraction ratio : 50.0:1.0 Dry plant equivalent : 50.0 mg Potency : 95.0 % Piperine | 1.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Used in Herbal Medicine as a diuretic. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking any other medications or natural health products, as black pepper/piperine may alter their effectiveness. Consult a health care practitioner prior to use if you have an iron deficiency. Consult a health care practitioner prior to use if you have liver or gall bladder diseases, and/or intestinal obstruction,. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have a history of kidney stones. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have a fever, painful urination (dysuria), spasms, or blood in urine. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
- Contre-indications
Do not use if you are pregnant or breastfeeding or if you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics.
Source
Official Health Canada record, licence 80070166
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.